WOAG
WITHDRAWAL OF ATTORNEY GRANTED
05/22/2026
Back to search
Official data from USPTO
IDEA INNOVATIVE DIABETES AND ENDOCRINE ASSOCIATES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/29/2026
Trademark type
Combined
Nice classes
44
Filing date
10/29/2021
Registration date
07/01/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2025
Last transaction
05/29/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/05/2025
First use in commerce
02/05/2025
Drawing code
3
Owner type
03
Owner location
Atlanta, GA, US
Examiner
NOVAKOVIC, MIROSLAV
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a graphic of a light bulb. The word "IDEA" appears within the top of the light bulb with horizontal lines extending from the letters "I" and "A" to the edge of the light bulb. Below the word "IDEA" in the center of the light bulb is a small circle under which is an inverted concave triangle. The word "INNOVATIVE" appears below the light bulb graphic. The words "DIABETES AND ENDCORINE ASSOCIATES" appear below the word "INNOVATIVE."
Holders and representatives
Holders
Atlanta Diabetes Associates, P.C.
Representatives
Atlanta Diabetes Associates, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicestreatment of diabetes and endocrine system disordersspecifically excluding providing information over the Internet relating to the treatment of diabetes and endocrine system disorders
Publications
History of USPTO decisions and trademark events.
32 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
05/22/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/10/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2025
IUAF
USE AMENDMENT FILED
02/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBO
PUBLISHED FOR OPPOSITION
09/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2024
DOCK
ASSIGNED TO EXAMINER
05/16/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2023
GNRT
NON-FINAL ACTION E-MAILED
03/07/2023
CNRT
NON-FINAL ACTION WRITTEN
03/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2022
GNRT
NON-FINAL ACTION E-MAILED
07/12/2022
CNRT
NON-FINAL ACTION WRITTEN
07/12/2022
DOCK
ASSIGNED TO EXAMINER
06/08/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/11/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2021
NWAP
NEW APPLICATION ENTERED
11/02/2021
Continuous trademark protection
Get notified about every new filing that threatens IDEA INNOVATIVE DIABETES AND ENDOCRINE ASSOCIATES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.